The search for novel adjuvants for early life vaccinations: Can "danger" motifs show us the way?

Archivum Immunologiae et Therapiae Experimentalis

Volumn 49, Issue 3, 2001, Pages 209-215

  Kovarik, Jiri ^a,b   Siegrist, Claire Anne ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Adjuvants; Infants; Newborns; Vaccines

Indexed keywords

ANTIGEN; BACTERIAL DNA; COMPLEMENT RECEPTOR; CYTOKINE; DRUG RECEPTOR; IMMUNOLOGICAL ADJUVANT; MANNOSE RECEPTOR; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CHILD CARE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; INFANT; MOLECULAR MIMICRY; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NEWBORN; NEWBORN CARE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANTIGEN-PRESENTING CELLS; DNA, BACTERIAL; DROSOPHILA PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MEMBRANE GLYCOPROTEINS; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; TOLL-LIKE RECEPTORS; VACCINATION; VACCINES, SUBUNIT;

EID: 0034899878     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. ABBAS A. K., MURPHY K. M. and SHER A. (1996): Functional diversity of helper T lymphocytes. Nature, 383, 787-793.
2. ADKINS B., GHANEI A. and HAMILTON K. (1993): Developmental regulation of IL-4, IL-2, and IFN-γ production by murine peripheral T lymphocytes. J. Immunol., 151, 6617-6626.
3. ADKINS B. and HAMILTON K. (1992): Freshly isolated, murine neonatal T cells produce IL-4 in response to anti-CD3 stimulation. J. Immunol., 149, 3448-3455.
4. BACHMAIER K., NEU N., dE lA MAZA L. M., PAL S., HESSEL A. and PENNINGER J. M. (1999): Chlamydia infections and heart disease linked through antigenic mimicry. Science, 283, 1335-1339.
5. BALLAS Z. K., RASMUSSEN W. L. and KRIEG A. M. (1996): Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol., 157, 1840-1845.
6. BARRIOS C., BRANDT C., BERNEY M., LAMBERT P. H. and SIEGRIST C. A. (1996): Partial correction of the Th2/Th1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur. J. Immunol., 26, 2666-2670.
7. BARRIOS C., BRAWAND P., BERNEY M., BRANDT C., LAMBERT P. H. and SIEGRIST C. A. (1996): Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol., 26, 1489-1496.
8. BIRON C. A., NGUYEN K. B., PIEN G. C., COUSENS L. P. and SALAZAR-MATHER T. P. (1999): Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol., 17, 189-220.
9. BOCCACCIO G. L., MOR F. and STEINMAN L. (1999): Non-coding plasmid DNA induces IFN-γ in vivo and suppresses autoimmune encephalomyelitis. Int. Immunol., 11, 289-296.
10. BOT A., ANTOHI S., BOT S., GARCIA-SASTRE A. and BONA C. (1997): Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Int. Immunol., 9, 1641-1650.
11. BRAZOLOT MILLAN C. L., WEERATNA R., KRIEG A. M., SIEGRIST C. A. and DAVIS H. L. (1998): CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA, 95, 15553-15558.
12. BREWER J. M., CONACHER M., SATOSKAR A., BLUETHMANN H. and ALEXANDER J. (1996): In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur. J. Immunol., 26, 2062-2066.
13. CHU R. S., TARGONI O. S., KRIEG A. M., LEHMANN P. V. and HARDING C. V. (1997): CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med., 186, 1623-1631.
14. DEMPSEY P. W , ALLISON M. E., AKKARAJU S., GOODNOW C. C. and FEARON D. T. (1996): C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science, 271, 348-350.
15. DINARELLO C. A. (1996): Cytokines as mediators in the pathogenesis of septic shock. Curr. Top. Microbiol. Immunol., 216, 133-165.
16. DONG X., STORKUS W. J. and SALTER R. D. (1999): Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J. Immunol., 163, 5427-5434.
17. ENGERING A. J., CELLA M., FLUITSMA D., BROCKHAUS M., HOEFSMIT E. C., LANZAVECCHIA A. and PIETERS J. (1997): The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol., 27, 2417-2425.
18. FEARON D. T. and LOCKSLEY R. M. (1996): The instructive role of innate immunity in the acquired immune response. Science, 272, 50-53.
19. FORSTHUBER T., YIP H. C. and LEHMANN P. V. (1996): Induction of Th1 and Th2 immunity in neonatal mice. Science, 271, 1728-1730.
20. GANS H. A., MALDONADO Y., YASUKAWA L. L., BEELER J., AUDET S., RINKI M. M., DEHOVITZ R. and ARVIN A. M. (1999): IL-12, IFN-γ, and T cell proliferation to measles in immunized infants. J. Immunol., 162, 5569-5575.
21. GICQUEL B. (1995): BCG as a vector for the construction of multivalent recombinant vaccines. Biologicals, 23, 113-118.
22. GILKESON G. S., RUIZ P., PIPPEN A. M., ALEXANDER A. L., LEFKOWITH J. B. and PISETSKY D. S. (1996): Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J. Exp. Med., 183, 1389-1397.
23. GORDON D. M., MCGOVERN T. W., KRZYCH U., COHEN J. C., SCHNEIDER I., LACHANCE R., HEPPNER D. G., YUAN G., HOLLINGDALE M. and SLAOUI M. (1995): Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J. Infect. Dis., 171, 1576-1785.
24. GUSTAFSON G. L., RHODES M. J. and HEGEL T. (1995): Monophosphoryl lipid A as a prophylactic for sepsis and septic shock. Prog. Clin. Biol. Res., 392, 567-579.
25. HUNT D. W., HUPPERTZ H. I., JIANG H. J. and PETTY R. E. (1994): Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood, 84, 4333-4343.
26. JANEWAY C. A. JR. (1992): The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today, 13, 11-16.
27. JOHNSTON R. B. JR. (1998): Function and cell biology of neutrophils and mononuclear phagocytes in the newborn infant. Vaccine, 16, 1363-1368.
28. KLINMAN D. M., YI A. K., BEAUCAGE S. L., CONOVER J. and KRIEG A. M. (1996): CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. USA, 93, 2879-2883.
29. KOVARIK J., BOZZOTTI P., LOVE-HOMAN L., PIHLGREN M., DAVIS H. L., LAMBERT P. H., KRIEG A. M. and SIEGRIST C. A. (1999): CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J. Immunol., 162, 1611-1617.
30. KOVARIK J. and SIEGRIST C. A. (1998): Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators. Immunol. Cell Biol., 76, 222-236.
31. KRIEG A. M., YI A. K., MATSON S., WALDSCHMIDT T. J., BISHOP G. A., TEASDALE R., KORETZKY G. A. and KLINMAN D. M. (1995): CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546-549.
32. KUBOTA H., WILLISON K., ASHWORTH A., NOZAKI M., MIYAMOTO H., YAMAMOTO H., MATSUSHIRO A. and MORITA T. (1992): Structure and expression of the gene encoding mouse t-complex polypeptide (Tcp-1). Gene, 120, 207-215.
33. LEE S. M., SUEN Y., CHANG L., BRUNER V., QIAN J., INDES J., KNOPPEL E., VAN DE VEN C. and CAIRO M. S. (1996): Decreased interleukin 12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon γ, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood, 88, 945-954.
34. LUCAS A. H., AZMI F. H., MINK C. M. and GRANOFF D. M. (1993): Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. J. Immunol., 150, 2056-2061.
35. MARCHANT A., GOETGHEBUER T., OTA M. O., WOLFE I., CEESAY S. I., DE GROOTE D., CORRAH T., BENNETT S., WHEELER J., HUYGEN K., AABY P., MCADAM K. P. and NEWPORT M. J. (1999): Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J. Immunol., 163, 2249-2255.
36. MARODI L., KAPOSZTA R., CAMPBELL D. E., POLIN R. A., CSONGOR J. and JOHNSTON R. B. JR. (1994): Candidacidal mechanisms in the human neonate. Impaired IFN-γ activation of macrophages in newborn infants. J. Immunol., 153, 5643-5649.
37. MARTINEZ X., BRANDT C., SADDALLAH F., TOUGNE C., BARRIOS C., WILD F., DOUGAN G., LAMBERT P. H. and SIEGRIST C. A. (1997): DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. USA, 94, 8726-8731.
38. MEDZHITOV R. and JANEWAY C. A. JR. (1997): Innate immunity: the virtues of a nonclonal system of recognition. Cell, 91, 295-298.
39. MESSINA J. P., GILKESON G. S. and PISETSKY D. S. (1991): Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol., 147, 1759-1764.
40. MOR G., SINGLA M., STEINBERG A. D., HOFFMAN S. L., OKUDA K. and KLINMAN D. M. (1997): Do DNA vaccines induce autoimmune disease? Hum. Gene Ther., 8, 293-300.
41. PETTY R. E. and HUNT D. W. (1998): Neonatal dendritic cells. Vaccine, 16, 1378-1382.
42. QIAN J. X., LEE S. M., SUEN Y., KNOPPEL E., VAN DE VEN C. and CAIRO M. S. (1997): Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood, 90, 3106-3117.
43. RUKERS G. T., SANDERS E. A., BREUKELS M. A. and ZEGERS B. J. (1998): Infant B cell responses to polysaccharide determinants. Vaccine, 16, 1396-1400.
44. SARZOTTI M., ROBBINS D. S. and HOFFMAN P. M. (1996): Induction of protective CTL responses in newborn mice by a murine retrovirus. Science, 271, 1726-1728.
45. SCHROEDER H. W. JR., MORTARI F., SHIOKAWA S., KIRKHAM P. M., ELGAVISH R. A. and BERTRAND F. E. 3rd (1995): Developmental regulation of the human antibody repertoire. Ann. NY Acad. Sci., 764, 242-260.
46. SCOTT M. E., KUBIN M. and KOHL S. (1997): High level interleukin-12 production, but diminished interferon-γ production, by cord blood mononuclear cells. Pediatr. Res., 41, 547-553.
47. SHIBATA Y., METZGER W. J. and MYRVIK Q. N. (1997): Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J. Immunol., 159, 2462-2467.
48. SHIMADA S., YANO O., INOUE H., KURAMOTO E., FUKUDA T., YAMAMOTO H., KATAOKA T. and TOKUNAGA T. (1985): Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J. Natl. Cancer Inst., 74, 681-688.
49. SIEGRIST C. A. (2000): Vaccination in the neonatal period and early infancy. Int. Rev. Immunol., 19, 195-219.
50. SIEGRIST C. A., SADDALLAH F., TOUGNE C., MARTINEZ X., KOVARIK J. and LAMBERT P. H. (1998): Induction of neonatal Th1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells? Vaccine, 16, 1473-1478.
51. SPARWASSER T., MIETHKE T., LIPFORD G., BORSCHERT K., HACKER H., HEEG K. and WAGNER H. (1997): Bacterial DNA causes septic shock. Nature, 386, 336-337.
52. STAHL P. D. and EZEKOWITZ R. A. (1998): The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol., 10, 50-55.
53. TSUNODA I., TOLLEY N. D., THEIL D. J., WHITTON J. L., KOBAYASHI H. and FUJINAMI R. S. (1999): Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol., 9, 481-493.
54. ULEVITCH R. J. and TOBIAS P. S. (1995): Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol., 13, 437-457.
55. VERHASSELT V., BUELENS C., WILLEMS F., DE GROOTE D., HAEFFNER-CAVAILLON N. and GOLDMAN M. (1997): Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol., 158, 2919-2925.
56. VILLIERS M. B., VILLIERS C. L., LAHARIE A. M. and MARCHE P. N. (1999): Amplification of the antibody response by C3b complexed to antigen through an ester link. J. Immunol., 162, 3647-3652.
57. WAGNER H. (1999): Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol., 73, 329-368.
58. YAMAMOTO Y., KLEIN T. W. and FRIEDMAN H. (1997): Involvement of mannose receptor in cytokine interleukin-1β (IL-1β), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1β (MIP-1β), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect. Immun., 65, 1077-1082.
59. YANG R. B., MARK M. R., GRAY A., HUANG A., XIE M. H., ZHANG M., GODDARD A., WOOD W. I., GURNEY A. L. and GODOWSKI P. J. (1998): Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature, 395, 284-288.
60. ZBAR B. and TANAKA T. (1971): Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis. Science, 172, 271-273.